MedTrace Logo

Hybrid PET/MR in the Therapy of Cervical Cancer

NCT01759355 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2021-12-03

No results posted yet for this study

Summary

This is a two arm, single center feasibility study of 20 patients with non-metastatic cervical cancer managed with surgery and/or chemoradiation therapy at UNC Hospitals. Subjects will undergo PET/MRI scans before, during (chemoradiation group only), and after treatment.

Conditions

  • Cervix Carcinoma
  • Cervical Squamous Cell Carcinoma
  • Cervical Adenosquamous Carcinoma

Interventions

PROCEDURE

FDG PET/MR

Participants will undergo a FDG, gadolinium enhanced PET/MR scan.

Sponsors & Collaborators

  • UNC Lineberger Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Jorge Oldan, MD · University of North Carolina, Chapel Hill

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2020-05-28
Completion
2020-05-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01759355 on ClinicalTrials.gov